In Brief: Minoxidil study
This article was originally published in The Rose Sheet
Minoxidil study: In a randomized, double-blind study of 22 women who suffered hair loss as a result of adjuvant chemotherapy after breast surgery, the period of baldness before first hair regrowth was shortened by a mean of 50.2 days for those using 2% minoxidil rather than placebo, Madeleine Duvic, MD, M.D. Anderson Cancer Center, et al. reported in the July issue of the Journal of the American Academy of Dermatology. The study was supported by a grant from Upjohn; Pharmacia & Upjohn markets OTC Rogaine 2% minoxidil hair regrowth treatment...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review